Workflow
春立医疗9月18日获融资买入591.42万元,融资余额3683.74万元
Xin Lang Cai Jing·2025-09-19 04:23

Group 1 - The core business of the company is focused on the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [2] - As of June 30, 2025, the company achieved a revenue of 488 million yuan, representing a year-on-year growth of 28.27%, and a net profit attributable to shareholders of 114 million yuan, with a year-on-year increase of 44.85% [2] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [3] Group 2 - As of September 18, 2023, the company's financing balance was 36.84 million yuan, accounting for 0.56% of its market capitalization, indicating a high level of financing activity [1] - The company had a total of 5,920 shareholders as of June 30, 2025, with a decrease of 17.57% compared to the previous period, while the average circulating shares per person increased by 341.41% [2] - The top ten circulating shareholders include significant institutional investors, with notable changes in holdings, such as an increase in shares held by Ping An Low Carbon Economy Mixed A [3]